Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Interaction between Cdc37 and Cdk4 in human cells.

Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, Draetta GF, Gyuris J.

Oncogene. 1997 Apr 24;14(16):1999-2004.

2.

Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.

Stepanova L, Leng X, Parker SB, Harper JW.

Genes Dev. 1996 Jun 15;10(12):1491-502.

3.

Identification of a conserved sequence motif that promotes Cdc37 and cyclin D1 binding to Cdk4.

Zhao Q, Boschelli F, Caplan AJ, Arndt KT.

J Biol Chem. 2004 Mar 26;279(13):12560-4. Epub 2003 Dec 30.

4.

Physical interaction of mammalian CDC37 with CDK4.

Dai K, Kobayashi R, Beach D.

J Biol Chem. 1996 Sep 6;271(36):22030-4.

5.

Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells.

Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM, Stampfer MR.

Mol Cell Biol. 1997 May;17(5):2458-67.

6.

Cdc37 enhances proliferation and is necessary for normal human prostate epithelial cell survival.

Schwarze SR, Fu VX, Jarrard DF.

Cancer Res. 2003 Aug 1;63(15):4614-9.

7.

Identification of CDK4 sequences involved in cyclin D1 and p16 binding.

Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, Price S, Webster KR.

J Biol Chem. 1997 Jul 25;272(30):18869-74.

8.
9.

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.

Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ.

Mol Cell Biol. 1995 May;15(5):2672-81.

10.

Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.

Morisaki H, Ando A, Nagata Y, Pereira-Smith O, Smith JR, Ikeda K, Nakanishi M.

Exp Cell Res. 1999 Dec 15;253(2):503-10.

PMID:
10585273
11.

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Toyoshima H, Hunter T.

Cell. 1994 Jul 15;78(1):67-74.

PMID:
8033213
12.

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano M, Hannon GJ, Beach D.

Nature. 1993 Dec 16;366(6456):704-7.

PMID:
8259215
13.
14.
15.

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.

Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y.

Genes Dev. 1994 Dec 15;8(24):2939-52.

16.

The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y.

EMBO J. 1996 Dec 16;15(24):7060-9.

17.

Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.

Ragione FD, Russo GL, Oliva A, Mercurio C, Mastropietro S, Pietra VD, Zappia V.

J Biol Chem. 1996 Jul 5;271(27):15942-9.

18.
19.

C/EBPalpha triggers proteasome-dependent degradation of cdk4 during growth arrest.

Wang H, Goode T, Iakova P, Albrecht JH, Timchenko NA.

EMBO J. 2002 Mar 1;21(5):930-41.

20.

A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases.

Bandhakavi S, McCann RO, Hanna DE, Glover CV.

J Biol Chem. 2003 Jan 31;278(5):2829-36. Epub 2002 Nov 14.

Items per page

Supplemental Content

Write to the Help Desk